BACKGROUND: General anesthesia is known to be associated with an increased risk for complications, especially in elderly and multi-morbid patients, the primary target population of the MitraClip(®) technique. The aim is to assess whether general anesthesia and even conscious sedation can be avoided during the MitraClip(®) procedure. METHODS: A total of 91 consecutive patients who underwent MitraClip(®) implantation [median 77 years, (IQR 72-83), 40 % female] were retrospectively analyzed. The first 26 patients were treated in general anesthesia. Afterwards, local anesthesia was chosen as primary anesthetic approach. Altogether, 28 (31 %) patients received general anesthesia, local anesthesia was performed in 35 (38 %) patients with sedation and in 28 (31 %) patients without sedation. RESULTS: The respective patient groups were similar regarding their baseline characteristics. Procedural success (successful implantation of at least one clip and post-procedure MR grade ≤2) was achieved in 89 % with no difference between the groups (93 % in general anesthesia, 89 % in local anesthesia with sedation, 86 % in local anesthesia without sedation, p = ns). No difference regarding hospital complications was noted. Local anesthesia with and without sedation was associated with less necessity for ICU/IMC stay (100 % in general anesthesia, 14 % in local anesthesia with sedation, 14 % in local anesthesia without sedation; p < 0.0001). One-year estimated survival was not significantly different among the groups (63, 82 and 75 %; p = ns). CONCLUSIONS: Transcatheter mitral valve repair with the MitraClip(®) can be performed without general anesthesia and even without conscious sedation with similar procedural success and complication rates.
BACKGROUND: General anesthesia is known to be associated with an increased risk for complications, especially in elderly and multi-morbid patients, the primary target population of the MitraClip(®) technique. The aim is to assess whether general anesthesia and even conscious sedation can be avoided during the MitraClip(®) procedure. METHODS: A total of 91 consecutive patients who underwent MitraClip(®) implantation [median 77 years, (IQR 72-83), 40 % female] were retrospectively analyzed. The first 26 patients were treated in general anesthesia. Afterwards, local anesthesia was chosen as primary anesthetic approach. Altogether, 28 (31 %) patients received general anesthesia, local anesthesia was performed in 35 (38 %) patients with sedation and in 28 (31 %) patients without sedation. RESULTS: The respective patient groups were similar regarding their baseline characteristics. Procedural success (successful implantation of at least one clip and post-procedure MR grade ≤2) was achieved in 89 % with no difference between the groups (93 % in general anesthesia, 89 % in local anesthesia with sedation, 86 % in local anesthesia without sedation, p = ns). No difference regarding hospital complications was noted. Local anesthesia with and without sedation was associated with less necessity for ICU/IMC stay (100 % in general anesthesia, 14 % in local anesthesia with sedation, 14 % in local anesthesia without sedation; p < 0.0001). One-year estimated survival was not significantly different among the groups (63, 82 and 75 %; p = ns). CONCLUSIONS:Transcatheter mitral valve repair with the MitraClip(®) can be performed without general anesthesia and even without conscious sedation with similar procedural success and complication rates.
Authors: K S Grewal; M J Malkowski; A R Piracha; J C Astbury; C M Kramer; S Dianzumba; N Reichek Journal: Am J Cardiol Date: 2000-01-15 Impact factor: 2.778
Authors: Ted Feldman; Hal S Wasserman; Howard C Herrmann; William Gray; Peter C Block; Patrick Whitlow; Fred St Goar; Leonardo Rodriguez; Frank Silvestry; Allan Schwartz; Timothy A Sanborn; Jose A Condado; Elyse Foster Journal: J Am Coll Cardiol Date: 2005-10-19 Impact factor: 24.094
Authors: Alexander Wutzler; Amélie Mueller; Lena Loehr; Martin Huemer; Abdul Shokor Parwani; Philipp Attanasio; Florian Blaschke; Christian Storm; Leif-Hendrik Boldt; Wilhelm Haverkamp Journal: Int J Cardiol Date: 2014-01-08 Impact factor: 4.164
Authors: Patrick L Whitlow; Ted Feldman; Wes R Pedersen; D Scott Lim; Robert Kipperman; Richard Smalling; Tanvir Bajwa; Howard C Herrmann; John Lasala; James T Maddux; Murat Tuzcu; Samir Kapadia; Alfredo Trento; Robert J Siegel; Elyse Foster; Donald Glower; Laura Mauri; Saibal Kar Journal: J Am Coll Cardiol Date: 2012-01-10 Impact factor: 24.094
Authors: Vasilis Babaliaros; Chandan Devireddy; Stamatios Lerakis; Robert Leonardi; Sebastian A Iturra; Kreton Mavromatis; Bradley G Leshnower; Robert A Guyton; Mihir Kanitkar; Patricia Keegan; Amy Simone; James P Stewart; Nima Ghasemzadeh; Peter Block; Vinod H Thourani Journal: JACC Cardiovasc Interv Date: 2014-07-30 Impact factor: 11.195
Authors: Wolfgang Schillinger; Mark Hünlich; Stephan Baldus; Taoufik Ouarrak; Peter Boekstegers; Ulrich Hink; Christian Butter; Raffi Bekeredjian; Björn Plicht; Horst Sievert; Joachim Schofer; Jochen Senges; Thomas Meinertz; Gerd Hasenfuß Journal: EuroIntervention Date: 2013-05-20 Impact factor: 6.534
Authors: Tommaso Bini; Cecilia Agostini; Miroslava Stolcova; Francesco Meucci; Carlo Di Mario Journal: Intern Emerg Med Date: 2019-07-11 Impact factor: 3.397
Authors: Michael M Kreusser; Andreas Weber; Nicolas A Geis; Leonie Grossekettler; Martin J Volz; Sonja Hamed; Hugo A Katus; Sven T Pleger; Norbert Frey; Philip W Raake Journal: ESC Heart Fail Date: 2021-09-08
Authors: Johannes Patzelt; Miriam Ulrich; Harry Magunia; Reinhard Sauter; Michal Droppa; Rezo Jorbenadze; Annika S Becker; Tobias Walker; Ralph Stephan von Bardeleben; Christian Grasshoff; Peter Rosenberger; Meinrad Gawaz; Peter Seizer; Harald F Langer Journal: J Am Heart Assoc Date: 2017-12-02 Impact factor: 5.501